Fenghuang “Frank” Zhan, Myeloma Center research director at the University of Arkansas for Medical Sciences, has received two grants of $3.14 million to study the molecular genetics and drug resistance of multiple myeloma.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
